Finafloxacin

Finafloxacin
Systematic (IUPAC) name

8-Cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b][1,4]oxazin-6(2H)-yl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
Clinical data
Trade names	Xtoro
Identifiers
CAS Number	209342-40-5
PubChem	CID 11567473
ChemSpider	9742243
ChEBI	CHEBI:85176^Y
ChEMBL	CHEMBL1908370
Chemical data
Formula	C₂₀H₁₉FN₄O₄
Molar mass	398.39 g/mol
SMILES C1CC1N2C=C(C(=O)C3=CC(=C(C(=C32)C#N)N4C[C@H]5[C@H](C4)OCCN5)F)C(=O)O
InChI InChI=1S/C20H19FN4O4/c21-14-5-11-17(25(10-1-2-10)7-13(19(11)26)20(27)28)12(6-22)18(14)24-8-15-16(9-24)29-4-3-23-15/h5,7,10,15-16,23H,1-4,8-9H2,(H,27,28)/t15-,16-/m0/s1 Key:FYMHQCNFKNMJAV-HOTGVXAUSA-N

Finafloxacin (Xtoro) is a fluoroquinolone antibiotic. In the United States, it is approved by the Food and Drug Administration to treat acute otitis externa (swimmer's ear) caused by the bacteria Pseudomonas aeruginosa and Staphylococcus aureus.^[1]

References

↑ "FDA approves Xtoro to treat swimmer’s ear". Food and Drug Administration. December 17, 2014.

This article is issued from Wikipedia - version of the Thursday, December 17, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.